SHE:002020 Revenue

Zhejiang Jingxin Pharmaceutical had revenue of 1.03B CNY in the quarter ending September 30, 2025, a decrease of -2.57%. This brings the company's revenue in the last twelve months to 4.00B, down -6.63% year-over-year. In the year 2024, Zhejiang Jingxin Pharmaceutical had annual revenue of 4.16B with 3.99% growth.

Revenue (ttm)

4.00B

Revenue Growth

-6.63%

P/S Ratio

3.38

Revenue / Employee

1.03M

Employees

3,869

Market Cap

13.53B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.16B	159.72M	3.99%
Dec 31, 2023	4.00B	218.99M	5.79%
Jan 1, 2023	3.78B	313.30M	9.04%
Jan 1, 2022	3.47B	208.47M	6.40%
Dec 31, 2020	3.26B	-388.61M	-10.66%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shanghai Shyndec Pharmaceutical	9.36B
Zhejiang Medicine	8.96B
Guobang Pharma	5.94B
Nanjing King-Friend Biochemical Pharmaceutical	3.76B
Porton Pharma Solutions	3.43B
Beijing Foyou Pharma CO.,LTD	3.42B
Tibet Rhodiola Pharmaceutical Holding Co.	2.72B
Wedge Industrial	1.24B

Revenue Rankings